CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 479 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,655,305 | +75.6% | 42,417 | +27.4% | 0.09% | +51.7% |
| Q3 2023 | $1,511,805 | +138.3% | 33,307 | +194.7% | 0.06% | +141.7% |
| Q2 2023 | $634,438 | -88.6% | 11,301 | -90.8% | 0.02% | -89.6% |
| Q1 2023 | $5,543,344 | +147.1% | 122,559 | +122.1% | 0.23% | +94.1% |
| Q4 2022 | $2,243,352 | +463.7% | 55,187 | +770.0% | 0.12% | +600.0% |
| Q1 2022 | $398,000 | +24.4% | 6,343 | +121.4% | 0.02% | -26.1% |
| Q3 2021 | $320,000 | -50.5% | 2,865 | -45.9% | 0.02% | -61.7% |
| Q1 2021 | $646,000 | – | 5,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |